Lisata Therapeutics And Qilu Pharmaceutical Announce First Patient Treated In Qilu's Phase 2 Trial Of LSTA1 In Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Lisata Therapeutics 和齐鲁制药宣布在齐鲁针对转移性胰腺导管腺癌患者的 LSTA1 二期试验中首次接受治疗的患者
Lisata Therapeutics And Qilu Pharmaceutical Announce First Patient Treated In Qilu's Phase 2 Trial Of LSTA1 In Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Lisata Therapeutics 和齐鲁制药宣布在齐鲁针对转移性胰腺导管腺癌患者的 LSTA1 二期试验中首次接受治疗的患者
使用浏览器的分享功能,分享给你的好友吧